CONNECT WITH US
HealthTech

HealthTech

Immune system protein is a cancer killer on its own, new study shows

Medical Xpress logo

Published on

Add as a preferred source on Google
Immune system protein is a cancer killer on its own, new study shows

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called granzymes, which kill the cell. Now, new work led by researchers at the University of Michigan Health Rogel Cancer Center found that tumor cells could be killed even when major granzymes were missing.

"If T cells and NK cells are the soldiers of the immune system, perforin is the weapon, and granzymes are the ammunition," said co-senior study author Weiping Zou, Charles B. de Nancrede professor of pathology, immunology, biology and surgery at U-M. "At least, that's what the classic understanding was."

Their new study, published in Cell, reveals that perforin is a cancer killer on its own, no major granzymes needed. They also found that a loss of perforin causes a catastrophic failure of antitumor immunity. The discoveries will likely have implications for understanding how cancers are killed by immune cells and could have ripple effects throughout the field of immunology.

"Our findings show, for the first time, that perforin can independently induce ferroptosis in tumor cells," said co-senior author Ilona Kryczek, a researcher at U-M.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.